- Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions. Oncotarget. 2017 Report GET IT
- Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Information Resource GET IT
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.
The New England journal of medicine.
Times cited: 9
- Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both. Leukemia. 2016 Academic Article GET IT
- Transcriptional plasticity promotes primary and acquired resistance to BET inhibition. Nature. 2015 Academic Article GET IT
- Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Article GET IT
- PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nature Medicine. 2012 Academic Article GET IT
- Standards and impact of hematopathology in myelodysplastic syndromes (MDS). Oncotarget. 2010 Information Resource GET IT